Morgan Stanley’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$535K Buy
325,457
+35,897
+12% +$59.1K ﹤0.01% 5434
2025
Q1
$527K Sell
289,560
-100,221
-26% -$182K ﹤0.01% 5304
2024
Q4
$1.45M Buy
389,781
+33,658
+9% +$125K ﹤0.01% 4902
2024
Q3
$1.14M Sell
356,123
-1,809,809
-84% -$5.79M ﹤0.01% 4980
2024
Q2
$17.8M Sell
2,165,932
-123,808
-5% -$1.02M ﹤0.01% 2795
2024
Q1
$33.2M Buy
2,289,740
+63,700
+3% +$923K ﹤0.01% 2150
2023
Q4
$20.5M Buy
2,226,040
+1,504,499
+209% +$13.9M ﹤0.01% 3324
2023
Q3
$11.9M Buy
721,541
+361,283
+100% +$5.96M ﹤0.01% 2962
2023
Q2
$2.28M Sell
360,258
-45,770
-11% -$289K ﹤0.01% 4346
2023
Q1
$1.38M Sell
406,028
-64,107
-14% -$218K ﹤0.01% 4681
2022
Q4
$2.72M Buy
470,135
+252,346
+116% +$1.46M ﹤0.01% 4251
2022
Q3
$2.05M Sell
217,789
-455,181
-68% -$4.28M ﹤0.01% 4415
2022
Q2
$15M Sell
672,970
-97,483
-13% -$2.17M ﹤0.01% 2601
2022
Q1
$42.4M Sell
770,453
-173,874
-18% -$9.56M 0.01% 1417
2021
Q4
$62.4M Buy
944,327
+9,768
+1% +$646K 0.01% 1191
2021
Q3
$78.4M Buy
934,559
+181,266
+24% +$15.2M 0.01% 979
2021
Q2
$95.6M Sell
753,293
-280,762
-27% -$35.6M 0.01% 872
2021
Q1
$113M Buy
1,034,055
+211,201
+26% +$23.2M 0.02% 698
2020
Q4
$117M Sell
822,854
-39,679
-5% -$5.66M 0.02% 648
2020
Q3
$60.9M Buy
862,533
+99,352
+13% +$7.01M 0.01% 812
2020
Q2
$53.4M Buy
763,181
+454,705
+147% +$31.8M 0.01% 813
2020
Q1
$10.8M Sell
308,476
-97,158
-24% -$3.4M ﹤0.01% 1708
2019
Q4
$25.5M Buy
405,634
+173,860
+75% +$10.9M 0.01% 1447
2019
Q3
$7.77M Buy
231,774
+218,597
+1,659% +$7.33M ﹤0.01% 2385
2019
Q2
$342K Buy
13,177
+11,645
+760% +$302K ﹤0.01% 4788
2019
Q1
$25K Sell
1,532
-30,554
-95% -$499K ﹤0.01% 5937
2018
Q4
$348K Buy
32,086
+16,193
+102% +$176K ﹤0.01% 5024
2018
Q3
$398K Buy
15,893
+3,357
+27% +$84.1K ﹤0.01% 5122
2018
Q2
$273K Buy
12,536
+658
+6% +$14.3K ﹤0.01% 5413
2018
Q1
$174K Buy
+11,878
New +$174K ﹤0.01% 5526